Cecha
Vomiting
Forceful ejection of the contents of the stomach through the mouth by means of a series of involuntary spasmic contractions.
Podsumowanie
- Znana także jako
- Throwing up, Emesis
- Układ organizmu
- Abnormality of the digestive system
Genom referencyjnyGRCh38hg38
Pozycje na stronach genów i wariantów zależą od tego wyboru, w tej przeglądarce.
Read the genes linked to Vomiting, and the rest of your genome, with one test.
Od 449 $Bezpłatna wysyłka · Wyniki w ciągu 6–8 tygodni
Zamawiam Genome Test352 genów powiązanych z Vomiting
Zmiany w tych genach powodują rzadkie choroby, w których występuje Vomiting. Większość osób z tą cechą nie ma żadnej z tych chorób, a gen z tej listy nic nie mówi o czyimkolwiek własnym genomie.
| Gen | Jak często występuje | Choroby |
|---|---|---|
| ABCB1ATP binding cassette subfamily B member 1 | Zawsze | W 1 chorobie |
| ACSL5acyl-CoA synthetase long chain family member 5 | Zawsze | W 1 chorobie |
| ALG11ALG11 alpha-1,2-mannosyltransferase | Zawsze | W 1 chorobie |
| ASXL3ASXL transcriptional regulator 3 | Zawsze | W 1 chorobie |
| ATP6V1B1ATPase H+ transporting V1 subunit B1 | Zawsze | W 1 chorobie |
| CLMPCXADR like cell adhesion molecule | Zawsze | W 1 chorobie |
| CYC1cytochrome c1 | Zawsze | W 1 chorobie |
| FARSBphenylalanyl-tRNA synthetase subunit beta | Zawsze | W 1 chorobie |
| FEM1Bfem-1 homolog B | Zawsze | W 1 chorobie |
| FLNAfilamin A | Zawsze | W 2 chorobach |
| GALTgalactose-1-phosphate uridylyltransferase | Zawsze | W 2 chorobach |
| GANgigaxonin | Zawsze | W 1 chorobie |
| GKglycerol kinase | Zawsze | W 1 chorobie |
| HMGCS23-hydroxy-3-methylglutaryl-CoA synthase 2 | Zawsze | W 1 chorobie |
| INPP4Ainositol polyphosphate-4-phosphatase type I A | Zawsze | W 1 chorobie |
| KARS1lysyl-tRNA synthetase 1 | Zawsze | W 2 chorobach |
| KDM6Blysine demethylase 6B | Zawsze | W 1 chorobie |
| KYNUkynureninase | Zawsze | W 1 chorobie |
| LIPAlipase A, lysosomal acid type | Zawsze | W 2 chorobach |
| MARS1methionyl-tRNA synthetase 1 | Zawsze | W 1 chorobie |
| MPImannose phosphate isomerase | Zawsze | W 2 chorobach |
| MTR5-methyltetrahydrofolate-homocysteine methyltransferase | Zawsze | W 1 chorobie |
| NDUFA2NADH:ubiquinone oxidoreductase subunit A2 | Zawsze | W 1 chorobie |
| NDUFS4NADH:ubiquinone oxidoreductase subunit S4 | Zawsze | W 2 chorobach |
| NEUROG3neurogenin 3 | Zawsze | W 2 chorobach |
| RFC4replication factor C subunit 4 | Zawsze | W 1 chorobie |
| RNU5B-1RNA, U5B small nuclear 1 | Zawsze | W 1 chorobie |
| RPL17ribosomal protein L17 | Zawsze | W 1 chorobie |
| SCN2Asodium voltage-gated channel alpha subunit 2 | Zawsze | W 2 chorobach |
| SCNN1Gsodium channel epithelial 1 subunit gamma | Zawsze | W 2 chorobach |
| SLC37A4solute carrier family 37 member 4 | Zawsze | W 1 chorobie |
| ST3GAL5ST3 beta-galactoside alpha-2,3-sialyltransferase 5 | Zawsze | W 1 chorobie |
| STX3syntaxin 3 | Zawsze | W 1 chorobie |
| TEFMtranscription elongation factor, mitochondrial | Zawsze | W 1 chorobie |
| TOM1target of myb1 membrane trafficking protein | Zawsze | W 1 chorobie |
| TRMUtRNA mitochondrial 2-thiouridylase | Zawsze | W 1 chorobie |
| TWNKtwinkle mtDNA helicase | Zawsze | W 1 chorobie |
| UQCC2ubiquinol-cytochrome c reductase complex assembly factor 2 | Zawsze | W 1 chorobie |
| UQCRHubiquinol-cytochrome c reductase hinge protein | Zawsze | W 1 chorobie |
| YARS1tyrosyl-tRNA synthetase 1 | Zawsze | W 1 chorobie |
Pokaż jeszcze 312 genów
| Gen | Jak często występuje | Choroby |
|---|---|---|
| ACAT1acetyl-CoA acetyltransferase 1 | Bardzo często (80–99%) | W 2 chorobach |
| CTNScystinosin, lysosomal cystine transporter | Bardzo często (80–99%) | W 2 chorobach |
| CYP11A1cytochrome P450 family 11 subfamily A member 1 | Bardzo często (80–99%) | W 2 chorobach |
| DLDdihydrolipoamide dehydrogenase | Bardzo często (80–99%) | W 1 chorobie |
| FOXRED1FAD dependent oxidoreductase domain containing 1 | Bardzo często (80–99%) | W 1 chorobie |
| GHSRgrowth hormone secretagogue receptor | Bardzo często (80–99%) | W 1 chorobie |
| HADHhydroxyacyl-CoA dehydrogenase | Bardzo często (80–99%) | W 1 chorobie |
| HIBCH3-hydroxyisobutyryl-CoA hydrolase | Bardzo często (80–99%) | W 1 chorobie |
| LIG3DNA ligase 3 | Bardzo często (80–99%) | W 1 chorobie |
| MT-ND1mitochondrially encoded NADH:ubiquinone oxidoreductase core subunit 1 | Bardzo często (80–99%) | W 2 chorobach |
| MT-ND2mitochondrially encoded NADH:ubiquinone oxidoreductase core subunit 2 | Bardzo często (80–99%) | W 1 chorobie |
| MT-ND3mitochondrially encoded NADH:ubiquinone oxidoreductase core subunit 3 | Bardzo często (80–99%) | W 1 chorobie |
| NDUFA1NADH:ubiquinone oxidoreductase subunit A1 | Bardzo często (80–99%) | W 1 chorobie |
| NDUFA11NADH:ubiquinone oxidoreductase subunit A11 | Bardzo często (80–99%) | W 1 chorobie |
| NDUFA6NADH:ubiquinone oxidoreductase subunit A6 | Bardzo często (80–99%) | W 1 chorobie |
| NDUFA9NADH:ubiquinone oxidoreductase subunit A9 | Bardzo często (80–99%) | W 1 chorobie |
| NDUFAF1NADH:ubiquinone oxidoreductase complex assembly factor 1 | Bardzo często (80–99%) | W 1 chorobie |
| NDUFAF2NADH:ubiquinone oxidoreductase complex assembly factor 2 | Bardzo często (80–99%) | W 1 chorobie |
| NDUFAF3NADH:ubiquinone oxidoreductase complex assembly factor 3 | Bardzo często (80–99%) | W 1 chorobie |
| NDUFAF4NADH:ubiquinone oxidoreductase complex assembly factor 4 | Bardzo często (80–99%) | W 1 chorobie |
| NDUFAF5NADH:ubiquinone oxidoreductase complex assembly factor 5 | Bardzo często (80–99%) | W 1 chorobie |
| NDUFAF8NADH:ubiquinone oxidoreductase complex assembly factor 8 | Bardzo często (80–99%) | W 1 chorobie |
| NDUFB10NADH:ubiquinone oxidoreductase subunit B10 | Bardzo często (80–99%) | W 1 chorobie |
| NDUFB11NADH:ubiquinone oxidoreductase subunit B11 | Bardzo często (80–99%) | W 1 chorobie |
| NDUFB3NADH:ubiquinone oxidoreductase subunit B3 | Bardzo często (80–99%) | W 1 chorobie |
| NDUFB9NADH:ubiquinone oxidoreductase subunit B9 | Bardzo często (80–99%) | W 1 chorobie |
| NDUFS1NADH:ubiquinone oxidoreductase core subunit S1 | Bardzo często (80–99%) | W 2 chorobach |
| NDUFS2NADH:ubiquinone oxidoreductase core subunit S2 | Bardzo często (80–99%) | W 2 chorobach |
| NDUFS3NADH:ubiquinone oxidoreductase core subunit S3 | Bardzo często (80–99%) | W 1 chorobie |
| NDUFS6NADH:ubiquinone oxidoreductase subunit S6 | Bardzo często (80–99%) | W 1 chorobie |
| NDUFS7NADH:ubiquinone oxidoreductase core subunit S7 | Bardzo często (80–99%) | W 1 chorobie |
| NDUFS8NADH:ubiquinone oxidoreductase core subunit S8 | Bardzo często (80–99%) | W 1 chorobie |
| NDUFV1NADH:ubiquinone oxidoreductase core subunit V1 | Bardzo często (80–99%) | W 2 chorobach |
| NDUFV2NADH:ubiquinone oxidoreductase core subunit V2 | Bardzo często (80–99%) | W 1 chorobie |
| NUBPLNUBP iron-sulfur cluster assembly factor, mitochondrial | Bardzo często (80–99%) | W 1 chorobie |
| POLGDNA polymerase gamma, catalytic subunit | Bardzo często (80–99%) | W 3 chorobach |
| RRM2Bribonucleotide reductase regulatory TP53 inducible subunit M2B | Bardzo często (80–99%) | W 2 chorobach |
| SLC22A5solute carrier family 22 member 5 | Bardzo często (80–99%) | W 2 chorobach |
| SSR4signal sequence receptor subunit 4 | Bardzo często (80–99%) | W 1 chorobie |
| TIMMDC1translocase of inner mitochondrial membrane domain containing 1 | Bardzo często (80–99%) | W 1 chorobie |
| TMEM126Btransmembrane protein 126B | Bardzo często (80–99%) | W 2 chorobach |
| TYMPthymidine phosphorylase | Bardzo często (80–99%) | W 2 chorobach |
| AAASaladin WD repeat nucleoporin | Często (30–79%) | W 1 chorobie |
| ACADMacyl-CoA dehydrogenase medium chain | Często (30–79%) | W 2 chorobach |
| AIPAHR interacting HSP90 co-chaperone | Często (30–79%) | W 1 chorobie |
| ALG8ALG8 alpha-1,3-glucosyltransferase | Często (30–79%) | W 2 chorobach |
| ASLargininosuccinate lyase | Często (30–79%) | W 2 chorobach |
| ASPAaspartoacylase | Często (30–79%) | W 1 chorobie |
| ASXL1ASXL transcriptional regulator 1 | Często (30–79%) | W 1 chorobie |
| ATP1A2ATPase Na+/K+ transporting subunit alpha 2 | Często (30–79%) | W 1 chorobie |
| ATP1A3ATPase Na+/K+ transporting subunit alpha 3 | Często (30–79%) | W 1 chorobie |
| ATP7BATPase copper transporting beta | Często (30–79%) | W 2 chorobach |
| AVParginine vasopressin | Często (30–79%) | W 1 chorobie |
| CACNA1Acalcium voltage-gated channel subunit alpha1 A | Często (30–79%) | W 2 chorobach |
| CARD8caspase recruitment domain family member 8 | Często (30–79%) | W 1 chorobie |
| CAV1caveolin 1 | Często (30–79%) | W 1 chorobie |
| CD55CD55 molecule (Cromer blood group) | Często (30–79%) | W 1 chorobie |
| CDH23cadherin related 23 | Często (30–79%) | W 2 chorobach |
| CDONcell adhesion associated, oncogene regulated | Często (30–79%) | W 4 chorobach |
| CLDN16claudin 16 | Często (30–79%) | W 1 chorobie |
| COL1A1collagen type I alpha 1 chain | Często (30–79%) | W 1 chorobie |
| COL4A5collagen type IV alpha 5 chain | Często (30–79%) | W 1 chorobie |
| COL4A6collagen type IV alpha 6 chain | Często (30–79%) | W 1 chorobie |
| COL5A1collagen type V alpha 1 chain | Często (30–79%) | W 1 chorobie |
| COL5A2collagen type V alpha 2 chain | Często (30–79%) | W 1 chorobie |
| CPT2carnitine palmitoyltransferase 2 | Często (30–79%) | W 2 chorobach |
| CRIPTOcripto, EGF-CFC family member | Często (30–79%) | W 4 chorobach |
| CTNNB1catenin beta 1 | Często (30–79%) | W 1 chorobie |
| CYP11B2cytochrome P450 family 11 subfamily B member 2 | Często (30–79%) | W 2 chorobach |
| DISP1dispatched RND transporter family member 1 | Często (30–79%) | W 4 chorobach |
| DLL1delta like canonical Notch ligand 1 | Często (30–79%) | W 4 chorobach |
| FBP1fructose-bisphosphatase 1 | Często (30–79%) | W 1 chorobie |
| FBXL4F-box and leucine rich repeat protein 4 | Często (30–79%) | W 1 chorobie |
| FGF8fibroblast growth factor 8 | Często (30–79%) | W 4 chorobach |
| FGFR1fibroblast growth factor receptor 1 | Często (30–79%) | W 2 chorobach |
| FOXH1forkhead box H1 | Często (30–79%) | W 4 chorobach |
| GAS1growth arrest specific 1 | Często (30–79%) | W 4 chorobach |
| GBA1glucosylceramidase beta 1 | Często (30–79%) | W 1 chorobie |
| GLI2GLI family zinc finger 2 | Często (30–79%) | W 4 chorobach |
| GMPPAGDP-mannose pyrophosphorylase A | Często (30–79%) | W 1 chorobie |
| GPD1glycerol-3-phosphate dehydrogenase 1 | Często (30–79%) | W 1 chorobie |
| HNF4Ahepatocyte nuclear factor 4 alpha | Często (30–79%) | W 1 chorobie |
| HSD3B2hydroxy-delta-5-steroid dehydrogenase, 3 beta- and steroid delta-isomerase 2 | Często (30–79%) | W 1 chorobie |
| ITGB4integrin subunit beta 4 | Często (30–79%) | W 1 chorobie |
| IVDisovaleryl-CoA dehydrogenase | Często (30–79%) | W 2 chorobach |
| MC2Rmelanocortin 2 receptor | Często (30–79%) | W 1 chorobie |
| MEN1menin 1 | Często (30–79%) | W 2 chorobach |
| METMET proto-oncogene, receptor tyrosine kinase | Często (30–79%) | W 1 chorobie |
| MMACHCmetabolism of cobalamin associated C | Często (30–79%) | W 1 chorobie |
| MMUTmethylmalonyl-CoA mutase | Często (30–79%) | W 1 chorobie |
| MPV17mitochondrial inner membrane protein MPV17 | Często (30–79%) | W 1 chorobie |
| MRAPmelanocortin 2 receptor accessory protein | Często (30–79%) | W 1 chorobie |
| MRPL39mitochondrial ribosomal protein L39 | Często (30–79%) | W 1 chorobie |
| MRPS7mitochondrial ribosomal protein S7 | Często (30–79%) | W 1 chorobie |
| MT-CO1mitochondrially encoded cytochrome c oxidase I | Często (30–79%) | W 1 chorobie |
| MT-CO2mitochondrially encoded cytochrome c oxidase II | Często (30–79%) | W 1 chorobie |
| MT-CO3mitochondrially encoded cytochrome c oxidase III | Często (30–79%) | W 1 chorobie |
| MT-ND4mitochondrially encoded NADH:ubiquinone oxidoreductase core subunit 4 | Często (30–79%) | W 1 chorobie |
| MT-ND5mitochondrially encoded NADH:ubiquinone oxidoreductase core subunit 5 | Często (30–79%) | W 1 chorobie |
| MT-ND6mitochondrially encoded NADH:ubiquinone oxidoreductase core subunit 6 | Często (30–79%) | W 1 chorobie |
| MT-TFmitochondrially encoded tRNA-Phe (UUU/C) | Często (30–79%) | W 1 chorobie |
| MT-THmitochondrially encoded tRNA-His (CAU/C) | Często (30–79%) | W 1 chorobie |
| MT-TL1mitochondrially encoded tRNA-Leu (UUA/G) 1 | Często (30–79%) | W 1 chorobie |
| MT-TL2mitochondrially encoded tRNA-Leu (CUN) 2 | Często (30–79%) | W 1 chorobie |
| MT-TQmitochondrially encoded tRNA-Gln (CAA/G) | Często (30–79%) | W 1 chorobie |
| MT-TS1mitochondrially encoded tRNA-Ser (UCN) 1 | Często (30–79%) | W 1 chorobie |
| MT-TS2mitochondrially encoded tRNA-Ser (AGU/C) 2 | Często (30–79%) | W 1 chorobie |
| MT-TWmitochondrially encoded tRNA-Trp (UGA/G) | Często (30–79%) | W 1 chorobie |
| MTRR5-methyltetrahydrofolate-homocysteine methyltransferase reductase | Często (30–79%) | W 1 chorobie |
| MVKmevalonate kinase | Często (30–79%) | W 2 chorobach |
| NAGSN-acetylglutamate synthase | Często (30–79%) | W 2 chorobach |
| NAXDNAD(P)HX dehydratase | Często (30–79%) | W 2 chorobach |
| NDUFB8NADH:ubiquinone oxidoreductase subunit B8 | Często (30–79%) | W 1 chorobie |
| NNTnicotinamide nucleotide transhydrogenase | Często (30–79%) | W 1 chorobie |
| NODALnodal growth differentiation factor | Często (30–79%) | W 4 chorobach |
| NR0B1nuclear receptor subfamily 0 group B member 1 | Często (30–79%) | W 1 chorobie |
| NUP214nucleoporin 214 | Często (30–79%) | W 1 chorobie |
| OTCornithine transcarbamylase | Często (30–79%) | W 1 chorobie |
| OXCT13-oxoacid CoA-transferase 1 | Często (30–79%) | W 2 chorobach |
| PHGDHphosphoglycerate dehydrogenase | Często (30–79%) | W 1 chorobie |
| PIGYphosphatidylinositol glycan anchor biosynthesis class Y | Często (30–79%) | W 1 chorobie |
| PLCH1phospholipase C eta 1 | Często (30–79%) | W 1 chorobie |
| PLECplectin | Często (30–79%) | W 1 chorobie |
| PMM2phosphomannomutase 2 | Często (30–79%) | W 2 chorobach |
| PRDX1peroxiredoxin 1 | Często (30–79%) | W 1 chorobie |
| PTCH1patched 1 | Często (30–79%) | W 4 chorobach |
| PYCR2pyrroline-5-carboxylate reductase 2 | Często (30–79%) | W 1 chorobie |
| RANBP2RAN binding protein 2 | Często (30–79%) | W 1 chorobie |
| RHOBTB2Rho related BTB domain containing 2 | Często (30–79%) | W 1 chorobie |
| RRM1ribonucleotide reductase catalytic subunit M1 | Często (30–79%) | W 1 chorobie |
| SAA1serum amyloid A1 | Często (30–79%) | W 1 chorobie |
| SAR1Bsecretion associated Ras related GTPase 1B | Często (30–79%) | W 2 chorobach |
| SCNN1Asodium channel epithelial 1 subunit alpha | Często (30–79%) | W 2 chorobach |
| SCNN1Bsodium channel epithelial 1 subunit beta | Często (30–79%) | W 1 chorobie |
| SERPING1serpin family G member 1 | Często (30–79%) | W 2 chorobach |
| SHHsonic hedgehog signaling molecule | Często (30–79%) | W 4 chorobach |
| SIsucrase-isomaltase | Często (30–79%) | W 1 chorobie |
| SIX3SIX homeobox 3 | Często (30–79%) | W 4 chorobach |
| SLC19A3solute carrier family 19 member 3 | Często (30–79%) | W 1 chorobie |
| SLC1A3solute carrier family 1 member 3 | Często (30–79%) | W 2 chorobach |
| SLC2A1solute carrier family 2 member 1 | Często (30–79%) | W 1 chorobie |
| SLC7A7solute carrier family 7 member 7 | Często (30–79%) | W 2 chorobach |
| SMC1Astructural maintenance of chromosomes 1A | Często (30–79%) | W 1 chorobie |
| STAG2STAG2 cohesin complex component | Często (30–79%) | W 2 chorobach |
| STARsteroidogenic acute regulatory protein | Często (30–79%) | W 1 chorobie |
| STILSTIL centriolar assembly protein | Często (30–79%) | W 4 chorobach |
| SYT1synaptotagmin 1 | Często (30–79%) | W 1 chorobie |
| TCN2transcobalamin 2 | Często (30–79%) | W 1 chorobie |
| TGIF1TGFB induced factor homeobox 1 | Często (30–79%) | W 4 chorobach |
| TNFRSF1ATNF receptor superfamily member 1A | Często (30–79%) | W 2 chorobach |
| TRAPPC11trafficking protein particle complex subunit 11 | Często (30–79%) | W 1 chorobie |
| TXNRD2thioredoxin reductase 2 | Często (30–79%) | W 1 chorobie |
| ZIC2Zic family zinc finger 2 | Często (30–79%) | W 4 chorobach |
| AASSaminoadipate-semialdehyde synthase | Czasami (5–29%) | W 1 chorobie |
| ABCC6ATP binding cassette subfamily C member 6 | Czasami (5–29%) | W 1 chorobie |
| ABCC8ATP binding cassette subfamily C member 8 | Czasami (5–29%) | W 1 chorobie |
| ACAD8acyl-CoA dehydrogenase family member 8 | Czasami (5–29%) | W 1 chorobie |
| ACSF3acyl-CoA synthetase family member 3 | Czasami (5–29%) | W 2 chorobach |
| ACY1aminoacylase 1 | Czasami (5–29%) | W 1 chorobie |
| ADNPactivity dependent neuroprotector homeobox | Czasami (5–29%) | W 1 chorobie |
| AGR2anterior gradient 2, protein disulphide isomerase family member | Czasami (5–29%) | W 1 chorobie |
| ALDOBaldolase, fructose-bisphosphate B | Czasami (5–29%) | W 2 chorobach |
| ALG9ALG9 alpha-1,2-mannosyltransferase | Czasami (5–29%) | W 1 chorobie |
| ALX4ALX homeobox 4 | Czasami (5–29%) | W 1 chorobie |
| AMNamnion associated transmembrane protein | Czasami (5–29%) | W 1 chorobie |
| ANAPC1anaphase promoting complex subunit 1 | Czasami (5–29%) | W 1 chorobie |
| BSNDbarttin CLCNK type accessory subunit beta | Czasami (5–29%) | W 1 chorobie |
| CD46CD46 molecule | Czasami (5–29%) | W 1 chorobie |
| CDKN1Bcyclin dependent kinase inhibitor 1B | Czasami (5–29%) | W 1 chorobie |
| CDKN2Bcyclin dependent kinase inhibitor 2B | Czasami (5–29%) | W 1 chorobie |
| CFHcomplement factor H | Czasami (5–29%) | W 1 chorobie |
| CFIcomplement factor I | Czasami (5–29%) | W 1 chorobie |
| CLCNKAchloride voltage-gated channel Ka | Czasami (5–29%) | W 1 chorobie |
| CLCNKBchloride voltage-gated channel Kb | Czasami (5–29%) | W 1 chorobie |
| COA8cytochrome c oxidase assembly factor 8 | Czasami (5–29%) | W 1 chorobie |
| COL25A1collagen type XXV alpha 1 chain | Czasami (5–29%) | W 1 chorobie |
| CTRCchymotrypsin C | Czasami (5–29%) | W 1 chorobie |
| CUBNcubilin | Czasami (5–29%) | W 1 chorobie |
| DBHdopamine beta-hydroxylase | Czasami (5–29%) | W 1 chorobie |
| DOLKdolichol kinase | Czasami (5–29%) | W 1 chorobie |
| DPYSdihydropyrimidinase | Czasami (5–29%) | W 1 chorobie |
| DYRK1Adual specificity tyrosine phosphorylation regulated kinase 1A | Czasami (5–29%) | W 1 chorobie |
| ENPP1ectonucleotide pyrophosphatase/phosphodiesterase 1 | Czasami (5–29%) | W 1 chorobie |
| FBXO11F-box protein 11 | Czasami (5–29%) | W 1 chorobie |
| FBXO22F-box protein 22 | Czasami (5–29%) | W 1 chorobie |
| FHfumarate hydratase | Czasami (5–29%) | W 1 chorobie |
| FOCADfocadhesin | Czasami (5–29%) | W 1 chorobie |
| FOXP3forkhead box P3 | Czasami (5–29%) | W 1 chorobie |
| GALCgalactosylceramidase | Czasami (5–29%) | W 2 chorobach |
| GFM2GTP dependent ribosome recycling factor mitochondrial 2 | Czasami (5–29%) | W 1 chorobie |
| GRB10growth factor receptor bound protein 10 | Czasami (5–29%) | W 1 chorobie |
| HELLPARHELLP associated long non-coding RNA | Czasami (5–29%) | W 1 chorobie |
| HIKESHIheat shock protein nuclear import factor hikeshi | Czasami (5–29%) | W 1 chorobie |
| IRAK1interleukin 1 receptor associated kinase 1 | Czasami (5–29%) | W 1 chorobie |
| KCNJ11potassium inwardly rectifying channel subfamily J member 11 | Czasami (5–29%) | W 1 chorobie |
| KICS2KICSTOR subunit 2 | Czasami (5–29%) | W 1 chorobie |
| KIF21Akinesin family member 21A | Czasami (5–29%) | W 1 chorobie |
| KITKIT proto-oncogene, receptor tyrosine kinase | Czasami (5–29%) | W 1 chorobie |
| LAMA3laminin subunit alpha 3 | Czasami (5–29%) | W 1 chorobie |
| LAMB3laminin subunit beta 3 | Czasami (5–29%) | W 1 chorobie |
| LAMC2laminin subunit gamma 2 | Czasami (5–29%) | W 1 chorobie |
| LRPPRCleucine rich pentatricopeptide repeat containing | Czasami (5–29%) | W 1 chorobie |
| MED12mediator complex subunit 12 | Czasami (5–29%) | W 1 chorobie |
| MEFVMEFV innate immunity regulator, pyrin | Czasami (5–29%) | W 1 chorobie |
| MLYCDmalonyl-CoA decarboxylase | Czasami (5–29%) | W 2 chorobach |
| MSX2msh homeobox 2 | Czasami (5–29%) | W 1 chorobie |
| MT-CYBmitochondrially encoded cytochrome b | Czasami (5–29%) | W 1 chorobie |
| MTTPmicrosomal triglyceride transfer protein | Czasami (5–29%) | W 1 chorobie |
| NAA10N-alpha-acetyltransferase 10, NatA catalytic subunit | Czasami (5–29%) | W 1 chorobie |
| NARS2asparaginyl-tRNA synthetase 2, mitochondrial | Czasami (5–29%) | W 1 chorobie |
| PCK1phosphoenolpyruvate carboxykinase 1 | Czasami (5–29%) | W 1 chorobie |
| PCK2phosphoenolpyruvate carboxykinase 2, mitochondrial | Czasami (5–29%) | W 1 chorobie |
| PGM1phosphoglucomutase 1 | Czasami (5–29%) | W 1 chorobie |
| PHOX2Apaired like homeobox 2A | Czasami (5–29%) | W 1 chorobie |
| PKHD1PKHD1 ciliary IPT domain containing fibrocystin/polyductin | Czasami (5–29%) | W 1 chorobie |
| PNPT1polyribonucleotide nucleotidyltransferase 1 | Czasami (5–29%) | W 2 chorobach |
| PSAPprosaposin | Czasami (5–29%) | W 1 chorobie |
| RARS1arginyl-tRNA synthetase 1 | Czasami (5–29%) | W 1 chorobie |
| RECQL4RecQ like helicase 4 | Czasami (5–29%) | W 1 chorobie |
| RYR1ryanodine receptor 1 | Czasami (5–29%) | W 1 chorobie |
| SAT1spermidine/spermine N1-acetyltransferase 1 | Czasami (5–29%) | W 1 chorobie |
| SLC22A12solute carrier family 22 member 12 | Czasami (5–29%) | W 1 chorobie |
| SLC25A13solute carrier family 25 member 13 | Czasami (5–29%) | W 1 chorobie |
| SLC2A9solute carrier family 2 member 9 | Czasami (5–29%) | W 1 chorobie |
| SLC5A1solute carrier family 5 member 1 | Czasami (5–29%) | W 1 chorobie |
| SPINK1serine peptidase inhibitor Kazal type 1 | Czasami (5–29%) | W 1 chorobie |
| SPOUT1SPOUT domain containing methyltransferase 1 | Czasami (5–29%) | W 1 chorobie |
| SPP1secreted phosphoprotein 1 | Czasami (5–29%) | W 1 chorobie |
| SPTBN1spectrin beta, non-erythrocytic 1 | Czasami (5–29%) | W 1 chorobie |
| STAT4signal transducer and activator of transcription 4 | Czasami (5–29%) | W 1 chorobie |
| STK11serine/threonine kinase 11 | Czasami (5–29%) | W 1 chorobie |
| SUCLG1succinate-CoA ligase GDP/ADP-forming subunit alpha | Czasami (5–29%) | W 1 chorobie |
| SYKspleen associated tyrosine kinase | Czasami (5–29%) | W 1 chorobie |
| TREHtrehalase | Czasami (5–29%) | W 1 chorobie |
| TUBA1Atubulin alpha 1a | Czasami (5–29%) | W 1 chorobie |
| TUBB2Btubulin beta 2B class IIb | Czasami (5–29%) | W 1 chorobie |
| TUBB3tubulin beta 3 class III | Czasami (5–29%) | W 1 chorobie |
| UFC1ubiquitin-fold modifier conjugating enzyme 1 | Czasami (5–29%) | W 1 chorobie |
| ZFTAzinc finger translocation associated | Czasami (5–29%) | W 1 chorobie |
| ZFXzinc finger protein X-linked | Czasami (5–29%) | W 1 chorobie |
| ACADVLacyl-CoA dehydrogenase very long chain | Rzadko (1–4%) | W 1 chorobie |
| ALDH18A1aldehyde dehydrogenase 18 family member A1 | Rzadko (1–4%) | W 2 chorobach |
| ELNelastin | Rzadko (1–4%) | W 1 chorobie |
| EPCAMepithelial cell adhesion molecule | Rzadko (1–4%) | W 1 chorobie |
| FBLN5fibulin 5 | Rzadko (1–4%) | W 1 chorobie |
| GFAPglial fibrillary acidic protein | Rzadko (1–4%) | W 1 chorobie |
| PHKA2phosphorylase kinase regulatory subunit alpha 2 | Rzadko (1–4%) | W 1 chorobie |
| PHKBphosphorylase kinase regulatory subunit beta | Rzadko (1–4%) | W 1 chorobie |
| PHKG2phosphorylase kinase catalytic subunit gamma 2 | Rzadko (1–4%) | W 1 chorobie |
| ACTG2actin gamma 2, smooth muscle | Nie odnotowano | W 1 chorobie |
| ALADaminolevulinate dehydratase | Nie odnotowano | W 1 chorobie |
| ALG3ALG3 alpha-1,3- mannosyltransferase | Nie odnotowano | W 1 chorobie |
| ALPLalkaline phosphatase, biomineralization associated | Nie odnotowano | W 1 chorobie |
| AQP2aquaporin 2 | Nie odnotowano | W 1 chorobie |
| ARG1arginase 1 | Nie odnotowano | W 1 chorobie |
| ASS1argininosuccinate synthase 1 | Nie odnotowano | W 1 chorobie |
| ATP6V0A4ATPase H+ transporting V0 subunit a4 | Nie odnotowano | W 1 chorobie |
| ATRXATRX chromatin remodeler | Nie odnotowano | W 1 chorobie |
| AVPR2arginine vasopressin receptor 2 | Nie odnotowano | W 1 chorobie |
| BCKDHAbranched chain keto acid dehydrogenase E1 subunit alpha | Nie odnotowano | W 1 chorobie |
| BOLA3bolA family member 3 | Nie odnotowano | W 1 chorobie |
| BRAFB-Raf proto-oncogene, serine/threonine kinase | Nie odnotowano | W 1 chorobie |
| BTDbiotinidase | Nie odnotowano | W 1 chorobie |
| CPOXcoproporphyrinogen oxidase | Nie odnotowano | W 2 chorobach |
| CPS1carbamoyl-phosphate synthase 1 | Nie odnotowano | W 1 chorobie |
| CYP24A1cytochrome P450 family 24 subfamily A member 1 | Nie odnotowano | W 1 chorobie |
| DGAT1diacylglycerol O-acyltransferase 1 | Nie odnotowano | W 1 chorobie |
| DGUOKdeoxyguanosine kinase | Nie odnotowano | W 1 chorobie |
| DHCR77-dehydrocholesterol reductase | Nie odnotowano | W 1 chorobie |
| EDNRAendothelin receptor type A | Nie odnotowano | W 1 chorobie |
| EGFRepidermal growth factor receptor | Nie odnotowano | W 1 chorobie |
| ELP1elongator acetyltransferase complex subunit 1 | Nie odnotowano | W 1 chorobie |
| ERBB3erb-b2 receptor tyrosine kinase 3 | Nie odnotowano | W 1 chorobie |
| ESR1estrogen receptor 1 | Nie odnotowano | W 1 chorobie |
| ETFAelectron transfer flavoprotein subunit alpha | Nie odnotowano | W 1 chorobie |
| ETFBelectron transfer flavoprotein subunit beta | Nie odnotowano | W 1 chorobie |
| ETFDHelectron transfer flavoprotein dehydrogenase | Nie odnotowano | W 1 chorobie |
| F12coagulation factor XII | Nie odnotowano | W 1 chorobie |
| GALEUDP-galactose-4-epimerase | Nie odnotowano | W 1 chorobie |
| GLAgalactosidase alpha | Nie odnotowano | W 1 chorobie |
| HLA-DQA1major histocompatibility complex, class II, DQ alpha 1 | Nie odnotowano | W 1 chorobie |
| HLA-DQB1major histocompatibility complex, class II, DQ beta 1 | Nie odnotowano | W 1 chorobie |
| HLCSholocarboxylase synthetase | Nie odnotowano | W 1 chorobie |
| HMBShydroxymethylbilane synthase | Nie odnotowano | W 1 chorobie |
| HPRT1hypoxanthine phosphoribosyltransferase 1 | Nie odnotowano | W 1 chorobie |
| KCNJ1potassium inwardly rectifying channel subfamily J member 1 | Nie odnotowano | W 1 chorobie |
| KMT2Elysine methyltransferase 2E (inactive) | Nie odnotowano | W 1 chorobie |
| KRASKRas proto-oncogene, GTPase | Nie odnotowano | W 1 chorobie |
| LPLlipoprotein lipase | Nie odnotowano | W 1 chorobie |
| MAP2K1mitogen-activated protein kinase kinase 1 | Nie odnotowano | W 1 chorobie |
| MAP2K2mitogen-activated protein kinase kinase 2 | Nie odnotowano | W 1 chorobie |
| MCCC1methylcrotonyl-CoA carboxylase subunit 1 | Nie odnotowano | W 1 chorobie |
| MCCC2methylcrotonyl-CoA carboxylase subunit 2 | Nie odnotowano | W 1 chorobie |
| MMAAmetabolism of cobalamin associated A | Nie odnotowano | W 1 chorobie |
| MMABmetabolism of cobalamin associated B | Nie odnotowano | W 1 chorobie |
| MTHFD1methylenetetrahydrofolate dehydrogenase, cyclohydrolase and formyltetrahydrofolate synthetase 1 | Nie odnotowano | W 1 chorobie |
| NBASNBAS subunit of NRZ tethering complex | Nie odnotowano | W 1 chorobie |
| NR3C2nuclear receptor subfamily 3 group C member 2 | Nie odnotowano | W 1 chorobie |
| OPLAH5-oxoprolinase, ATP-hydrolysing | Nie odnotowano | W 1 chorobie |
| PCCApropionyl-CoA carboxylase subunit alpha | Nie odnotowano | W 1 chorobie |
| PCCBpropionyl-CoA carboxylase subunit beta | Nie odnotowano | W 1 chorobie |
| PPM1Dprotein phosphatase, Mg2+/Mn2+ dependent 1D | Nie odnotowano | W 1 chorobie |
| PPOXprotoporphyrinogen oxidase | Nie odnotowano | W 1 chorobie |
| RETret proto-oncogene | Nie odnotowano | W 1 chorobie |
| SLC12A1solute carrier family 12 member 1 | Nie odnotowano | W 1 chorobie |
| SLC12A3solute carrier family 12 member 3 | Nie odnotowano | W 1 chorobie |
| SLC6A8solute carrier family 6 member 8 | Nie odnotowano | W 1 chorobie |
| SMPD1sphingomyelin phosphodiesterase 1 | Nie odnotowano | W 1 chorobie |
| SUGCTsuccinyl-CoA:glutarate-CoA transferase | Nie odnotowano | W 1 chorobie |
| TNFtumor necrosis factor | Nie odnotowano | W 1 chorobie |
| TP53tumor protein p53 | Nie odnotowano | W 1 chorobie |
| ZEB2zinc finger E-box binding homeobox 2 | Nie odnotowano | W 1 chorobie |
Jak często występuje wśród osób z jedną z chorób związanych z tym genem, najczęściej spośród wszystkich, według danych Human Phenotype Ontology. Te strony opisują cechy i badania, na których się opierają; nie są diagnozą, a w sprawie objawów należy zwrócić się do lekarza lub doradcy genetycznego.
Cechy podrzędne
Cechy nadrzędne
Skąd pochodzą te dane
- Human Phenotype Ontology, wydanie 2026-09-01: cecha, jej nazwy, definicja oraz geny z nią powiązane. Więcej informacji znajdą Państwo na stronie hpo.jax.org.
- Wydanie danych 2026.10.16-c6eea6bf.
Jeden test. Odpowiedzi na całe życie.
Od 449 $Bezpłatna wysyłka · Wyniki w ciągu 6–8 tygodni